Sonic Incytes Accepted Into Boston CTA
April 20, 2020
Sonic Incytes Medical Corp. is pleased to announce it has been selected to participate in the Canadian Technology Accelerator (CTA) 2020 program, along with 10 other promising start-ups in tech and life sciences from across Canada. The program will take place in Boston and runs from May to November 2020.
The Boston CTA is an award-winning non-equity program that connects Canadian tech and life science companies to US clients, strategic partners and investors.
It emphasizes aggressive business development and growth. Located at the Cambridge Innovation Center, the program offers customized team mentoring from successful entrepreneurs, investors and industry leaders.